Eli Lilly is moving closer to bringing its experimental weight loss pill, orforglipron, to market after releasing positive results from its latest phase 3 clinical trial. The study, called Attain-2, tested the once-daily pill in people who are overweight or obese and also have Type 2 diabetes—a group often harder to treat. The trial found
A large new study suggests that verbal abuse during childhood can be just as harmful to long-term mental health as physical abuse—and in some cases, even worse. Researchers from Liverpool John Moores University analyzed data from over 20,000 adults in England and Wales collected between 2012 and 2024. Participants reported whether they had experienced verbal
A major new study has found that drinking just one can of diet soda a day may raise your risk of developing type 2 diabetes by 38%. Surprisingly, this is a greater risk than what’s seen with regular sugary sodas. The study, led by researchers at Monash University, followed more than 36,000 adults aged 40
A recent clinical trial is offering new hope in the fight against HIV. Researchers tested a new type of vaccine using mRNA technology—the same method used in COVID-19 vaccines—to see if it could trigger strong immune responses against the virus. The trial, called HVTN 302, tested three different versions of an HIV vaccine in 108
A major new study from Denmark shows no link between aluminum in childhood vaccines and an increased risk of diseases like asthma or autism. Researchers examined health and vaccination records of over 1.2 million children from 1997 to 2018. They found no evidence that aluminum-containing vaccines cause harm. Aluminum salts are added to some vaccines
Donner du sang pourrait faire bien plus que venir en aide aux autres — cela pourrait aussi améliorer la santé de vos propres cellules sanguines. Une étude récente suggère que les dons de sang fréquents pourraient favoriser la croissance de mutations bénéfiques dans les cellules sanguines, réduisant potentiellement le risque de maladies liées au sang.
AstraZeneca prend de l’avance avec son inhalateur Breztri Aerosphere, visant à élargir son utilisation au-delà de la maladie pulmonaire obstructive chronique (MPOC) pour traiter également l’asthme. Cette démarche pourrait rapprocher l’entreprise de son objectif de ventes annuelles de 3 à 5 milliards de dollars. Breztri est un inhalateur « 3-en-1 » qui combine trois médicaments pour faciliter
Une étude internationale récente a révélé qu’une seule dose d’un nouveau vaccin contre le virus respiratoire syncytial (VRS), appelé RSVPreF3 OA, peut protéger les adultes âgés de 60 ans et plus contre les infections pulmonaires graves causées par le VRS pendant jusqu’à trois saisons consécutives. L’étude a porté sur plus de 24 000 adultes âgés répartis
La Food and Drug Administration (FDA) des États-Unis a approuvé Nucala (mépolizumab) comme traitement d’appoint pour les adultes atteints de maladie pulmonaire obstructive chronique (MPOC) qui continuent de présenter des exacerbations malgré une triple thérapie inhalée. Nucala est le premier médicament biologique spécifiquement approuvé pour les patients MPOC présentant un « phénotype éosinophilique » — un groupe
A recent study by Uppsala University and Chalmers University of Technology has found that coffee from many workplace coffee machines contains high levels of cholesterol-raising compounds. The research, published in Nutrition, Metabolism & Cardiovascular Diseases, highlights the difference between coffee brewed in these machines and coffee made using regular paper filter drip coffee makers.
